New Data Highlights Positive Results Of Namenda(R) (Memantine HCl) Once-Daily Extended-Release Formulation

Forest Laboratories, Inc. (NYSE: FRX) presented positive Phase III data of a once-daily extended-release formulation of Namenda® (memantine HCl) at the 2008 Alzheimer’s Association International Conference on Alzheimer’s Disease (ICAD).

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on August 7th, 2008